192 related articles for article (PubMed ID: 11816246)
1. Risk of gastric injury with enteric- versus nonenteric-coated aspirin.
Banoob DW; McCloskey WW; Webster W
Ann Pharmacother; 2002 Jan; 36(1):163-6. PubMed ID: 11816246
[TBL] [Abstract][Full Text] [Related]
2. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
Kelly JP; Kaufman DW; Jurgelon JM; Sheehan J; Koff RS; Shapiro S
Lancet; 1996 Nov; 348(9039):1413-6. PubMed ID: 8937281
[TBL] [Abstract][Full Text] [Related]
3. Is enteric aspirin safer than regular aspirin?
Johns Hopkins Med Lett Health After 50; 2013 Aug; 25(7):7. PubMed ID: 24386685
[No Abstract] [Full Text] [Related]
4. [Digestive and hemorrhage complications of low-dose aspirin].
Sibilia J; Ravaud P; Marck G
Presse Med; 2003 Nov; 32(37 Pt 2):S17-28. PubMed ID: 14763350
[TBL] [Abstract][Full Text] [Related]
5. Aspirin preparation and risk of GI bleeding.
Rao G
J Fam Pract; 1997 Mar; 44(3):242-3. PubMed ID: 9071237
[No Abstract] [Full Text] [Related]
6. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs.
Lanza FL
Scand J Gastroenterol Suppl; 1989; 163():24-31. PubMed ID: 2683026
[TBL] [Abstract][Full Text] [Related]
7. Persistence of gastric ulcers caused by plain aspirin or nonsteroidal antiinflammatory agents in patients treated with a combination of cimetidine, antacids, and enteric-coated aspirin.
Jaszewski R; Calzada R; Dhar R
Dig Dis Sci; 1989 Sep; 34(9):1361-4. PubMed ID: 2766902
[TBL] [Abstract][Full Text] [Related]
8. PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
Whellan DJ; Goldstein JL; Cryer BL; Eisen GM; Lanas A; Miller AB; Scheiman JM; Fort JG; Zhang Y; O'Connor C
Am Heart J; 2014 Oct; 168(4):495-502.e4. PubMed ID: 25262259
[TBL] [Abstract][Full Text] [Related]
9. Coated aspirin no safer.
Health News; 2000 Dec; 6(12):8. PubMed ID: 11142949
[No Abstract] [Full Text] [Related]
10. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration.
Guo W; Lu W; Xu Y; Wang L; Wei Q; Zhao Q
Clin Drug Investig; 2017 Feb; 37(2):187-193. PubMed ID: 27785736
[TBL] [Abstract][Full Text] [Related]
12. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
[TBL] [Abstract][Full Text] [Related]
13. Enteric-coated aspirin and gastric erosion.
Baum J
Hosp Pract; 1980 Apr; 15(4):16-7. PubMed ID: 6967444
[No Abstract] [Full Text] [Related]
14. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
Chowdhury A; Ganguly G; Chowdhury D; Santra A; Gupta JD; Roy T
Indian J Gastroenterol; 2001; 20(6):227-9. PubMed ID: 11817775
[TBL] [Abstract][Full Text] [Related]
15. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin.
Takada M; Fujimoto M; Hosomi K
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):181-91. PubMed ID: 24472400
[TBL] [Abstract][Full Text] [Related]
16. [Effect of non-steroidal anti-inflammatory drugs on the stomach].
Svintsitskiĭ AS
Klin Med (Mosk); 1990 Sep; 68(9):18-22. PubMed ID: 2290318
[No Abstract] [Full Text] [Related]
17. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.
Dammann HG; Burkhardt F; Wolf N
Aliment Pharmacol Ther; 1999 Aug; 13(8):1109-14. PubMed ID: 10468689
[TBL] [Abstract][Full Text] [Related]
18. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers.
Blondon H; Barbier JP; Mahé I; Deverly A; Kolsky H; Bergmann JF
Fundam Clin Pharmacol; 2000; 14(2):155-7. PubMed ID: 10796063
[TBL] [Abstract][Full Text] [Related]
19. Gastric safety and enteric-coated aspirin.
Guslandi M
Lancet; 1997 Feb; 349(9049):431. PubMed ID: 9033490
[No Abstract] [Full Text] [Related]
20. [Coxib spares the stomach. This is true also for patients with preventive aspirin administration].
MMW Fortschr Med; 2002 May; 144(20):62. PubMed ID: 12119888
[No Abstract] [Full Text] [Related]
[Next] [New Search]
